• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Establishment and Maintenance of a PBMC Repository for Functional Cellular Studies in Support of Clinical Vaccine Trials

tetano

Editor, Senior Moderator
J Immunol Methods. 2014 Apr 28. pii: S0022-1759(14)00122-7. doi: 10.1016/j.jim.2014.04.005. [Epub ahead of print]
Establishment and Maintenance of a PBMC Repository for Functional Cellular Studies in Support of Clinical Vaccine Trials.
Sambor A1, Garcia A2, Berrong M3, Pickeral J3, Brown S4, Rountree W2, Sanchez A2, Pollara J3, Frahm N5, Keinonen S2, Kijak GH6, Roederer M7, Levine G1, Patricia D'Souza M8, Jaimes M9, Koup R7, Denny T2, Cox J10, Ferrari G11.
Author information
Abstract

A large repository of cryopreserved peripheral blood mononuclear cells (PBMC) samples was created to provide laboratories testing the specimens from Human Immunodeficiency Virus-1 (HIV-1) vaccine clinical trials the material for assay development, optimization, and validation. One hundred thirty-one PBMC samples were collected using leukapheresis procedure between 2007 and 2013 by the Comprehensive T cell-Vaccine Immune Monitoring Consortium core repository. The donors included 83 Human Immunodeficiency Virus-1 (HIV-1) seronegative and 32 HIV-1 seropositive subjects. The samples were extensively characterized for the ability of T cell subsets to respond to recall viral antigens including Cytomegalovirus, Epstein-Barr virus, Influenza virus, and HIV-1 using Interferon-gamma (IFN-γ) Enzyme Linked ImmunoSpot (ELISpot) and IFN-γ/Interleukin 2 (IL-2) Intracellular Cytokine Staining (ICS) assays. A subset of samples was evaluated over time to determine the integrity of the cryopreserved samples in relation to recovery, viability, and functionality. The principal results of our study demonstrate that viable and functional cells were consistently recovered from the cryopreserved samples. Therefore, we determined that this repository of large size cryopreserved cellular samples constitutes an unique resource for laboratories who are involved in optimization and validation of assays to evaluate T, B, and NK cellular functions in the context of clinical trials.

Copyright ? 2014 Elsevier B.V. All rights reserved.
KEYWORDS:

Cryopreservation, Peripheral Blood Mononuclear Cells, Repository

PMID:
24787274
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24787274
 
Back
Top Bottom